MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Tom Davidson
Tom DavidsonLeerink Partners

Tom Davidson

Co-President at Leerink Partners

Financial Advisor

New York

Deal Bio

Total Deals6
Valued Deals6
Total Value£ 54.84 B
Avg. Deal Size£ 9.14 B

Market Context

Sort

03 Dec 2018|United States|Pharmaceuticals
Tesaro
Glaxosmithkline

Target: TESARO INC

Bidder: GLAXOSMITHKLINE PLC

13 Service Providers

7 Target | 6 Bidder

41 Dealmakers

30 Target | 11 Bidder

£ 3.37 B

Value

29 Jul 2019|United States|Pharmaceuticals
UPJOHN
Mylan

Target: UPJOHN

Bidder: MYLAN NV

20 Service Providers

1 Target | 9 Bidder | 10 Vendor

144 Dealmakers

1 Target | 78 Bidder | 65 Vendor

£ 18.11 B

Value

14 Dec 2021|Switzerland|Pharmaceuticals
Vifor Pharma
Csl

Target: VIFOR PHARMA AG

Bidder: CSL LIMITED

19 Service Providers

6 Target | 13 Bidder

74 Dealmakers

13 Target | 61 Bidder

£ 8.84 B

Value

12 Dec 2022|United States|Biotechnology
Horizon Therapeutics
Amgen

Target: HORIZON THERAPEUTICS

Bidder: AMGEN INC

15 Service Providers

8 Target | 7 Bidder

88 Dealmakers

24 Target | 64 Bidder

£ 22.86 B

Value

12 Aug 2024|United States|Biotechnology
Revance Therapeutics
Crown Laboratories

Target: REVANCE THERAPEUTICS INC

Bidder: CROWN LABORATORIES

10 Service Providers

4 Target | 6 Bidder

48 Dealmakers

21 Target | 27 Bidder

£ 724 M

Value

13 Jan 2025|United States|Biotechnology
IDRX
Glaxosmithkline

Target: IDRX

Bidder: GLAXOSMITHKLINE PLC

7 Service Providers

3 Target | 3 Bidder | 1 Vendor

51 Dealmakers

38 Target | 12 Bidder | 1 Vendor

£ 941 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite